Contributors

ELIA J. DUH • The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD

AZZA E.B. EL-REMESSY • College of Pharmacy, University of Georgia, Augusta, GA

YUXI FENG • 5th Medical Department, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany

FREDERICK L. FERRIS III • National Eye Institute, National Institutes of Health, Bethesda, Maryland

THOMAS W. GARDNER • The Penn State Retina Research Group,

Penn State University College of Medicine, Hershey, PA

MARK C. GILLIES • Department of Clinical Ophthalmology,

Save Sight Institute, University of Sydney, Australia

MARIA B. GRANT • Dept. of Pharmacology and Therapeutics, University of Florida, Gainesville, Florida

JULIA A. HALLER • The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland

ROLA HAMAM • Joslin Diabetes Center, Harvard Medical School, Boston, MA

HANS-PETER HAMMES • 5th Medical Department, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany

ANTONIA M. JOUSSEN • Department of Ophthalmology, University of Düsseldorf, Düsseldorf, Germany

PETER K. KAISER • Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH

TIMOTHY S. KERN • Department of Medicine, Case Western Reserve University, Cleveland, OH

GEORGE L. KING • Joslin Diabetes Center, Harvard Medical School, Boston, MA

RONALD KLEIN • Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI

RENU A. KOWLURU • Kresge Eye Institute, Wayne State University, Detroit, MI

ALEXANDER V. LJUBIMOV • Ophthalmology Research Laboratories, Cedars-Sinai Medical Center and Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA

MARA LORENZI • Schepens Eye Research Institute, Harvard Medical School, Boston, MA

CHENG MAO-LIN • Department of Cellular and Molecular Physiology and Ophthalmology, Penn State College of Medicine, Hershey, PA

RON MARGOLIS • Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH

PAUL G. MCGUIRE • Department of Surgery, and Cell Biology & Physiology, University of New Mexico School of Medicine, Albuquerque, NM

CATHERINE B. MEYERLE • National Eye Institute, National Institutes of Health, Bethesda, Maryland

DEEPTI NAVARATNA • Department of Cell Biology & Physiology, University of New Mexico School of Medicine, Albuquerque, NM

QUAN DONG NGUYEN • The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland

PETER J. OATES • Pfizer Global Research and Development, CVMED Department, Groton, CT

FREDERICK PFISTER • 5th Medical Department, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany

MANVI PRAKASH • Joslin Diabetes Center, Harvard Medical School, Boston, MA

SYED MAHMOOD SHAH • The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland

ALAN W. STITT • Centre for Vision Science, Queens University of Belfast, Northern Ireland, UK

CARLA STRIATA • Ophthalmology Europe, Pfizer Ltd UK

JENNIFER K. SUN • Joslin Diabetes Center, Harvard Medical School, Boston, MA

LAUREN E. SWENARCHUK • Zola Associates, Englewood Cliffs, New Jersey

HEATHER D. VANGUILDER • The Penn State Retina Research Group, Penn State University College of Medicine, Hershey, PA

LINDA E. WHETTER, DVM • Zola Associates, Englewood Cliffs, New Jersey

TIEN Y. WONG, FRANZCO • Centre for Eye Research Australia, the University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne